Clinical trials
Recruiting Phase 3 trials in Serbia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 5 |
| 2024 | 21 |
| 2025 | 26 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 80 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Neurocrine Biosciences | 4 |
| Sanofi | 4 |
| Boehringer Ingelheim | 3 |
| H. Lundbeck A/S | 3 |
| Intra-Cellular Therapies, Inc. | 3 |
| Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 3 |
| Octapharma | 3 |
| AbbVie | 2 |
| Italfarmaco | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 5 |
| Crohn Disease | 5 |
| Schizophrenia | 5 |
| Autoimmune Diseases | 3 |
| Hypertension | 3 |
| Major Depressive Disorder | 3 |
| Renal Insufficiency, Chronic | 3 |
| Bipolar Disorder | 2 |
| Carcinoma, Squamous Cell | 2 |
| Cardiovascular Diseases | 2 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.